| ED-TBI Followed By Allogeneic Stem Cell Transplantation For The Treatment Of Refractory AML And Advanced MDS (NCT01709396) | Ottawa Hospital Research Institute | 2012-01-01 |
| Respiratory Syncytial Virus - RSV Protocol (NCT01502072) | M.D. Anderson Cancer Center | 2011-12-28 |
| Change of Fatigue and Physical Fitness in Hospitalized Hematology Patients (NCT01603290) | National Taiwan University Hospital | 2011-12-01 |
| Pharmacokinetic Study of Busulfan in Allogeneic Stem Cell Transplantation in Adult Patients With Acute Leukemia (NCT01498016) | Shanghai Jiao Tong University School of Medicine | 2011-11-01 |
| Pharmacokinetic Study of Fludarabine in Pediatric Hematopoietic Stem Cell Transplantation (NCT01472055) | Seoul National University Hospital | 2011-10-01 |
| Patient Activation, Counseling and Exercise - Acute Leukemia (PACE-AL) (NCT01404520) | Universitetshospitalernes Center for Sygepleje | 2011-06-01 |
| Cohort Study of New Prognostic Factors With Peripheral Blood and Bone Marrow Evaluation at the Time of Diagnosis and During Treatment or Thereafter in Acute Leukemia (NCT02344966) | Yonsei University | 2011-06-01 |
| Clinical Study of PM01183 in Patients With Acute Leukemia or Relapsed/Refractory Myelodysplastic Syndrome (NCT01314599) | PharmaMar | 2011-05-01 |
| Bone Marrow Transplant Using a Reduced Intensity Regimen That is Given in Two Steps (NCT01350258) | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 2011-04-01 |
| Total Body Irradiation/Fludarabine Based Ablative Haploidentical Transplant for Hematologic Diseases (NCT01336712) | Northside Hospital, Inc. | 2011-04-01 |
| Prospective and Retrospective Cohort Study of New Prognostic Factors With Peripheral Blood and Bone Marrow Evaluation at the Time of Diagnosis and During Treatment or Thereafter in Acute Leukemia (Acute Leukemia HSCT Cohort) (NCT02344953) | Yonsei University | 2011-01-01 |
| Sequential Intensive Chemotherapy Followed by RIC for Refractory and Relapse AML (NCT01496547) | Shanghai Jiao Tong University School of Medicine | 2011-01-01 |
| Study of IRNEA (Irinotecan, Etoposide, Cytarabine) for Refractory or Relapsed Acute Leukemia in Children and Adolescents (NCT01239485) | Seoul National University Hospital | 2010-11-01 |
| Health Counseling and Exercise in Patients With Acute Leukemia - Pilot Study (NCT01557686) | Universitetshospitalernes Center for Sygepleje | 2010-05-01 |
| Evaluation of Plasmatic Levels of Busulfan in Patients Undergoing Hematopoietic Stem Cell Transplantation (NCT01800643) | Hospital Israelita Albert Einstein | 2010-03-01 |
| A Study of Withdrawal of Immunosuppression and Donor Lymphocyte Infusions Following Allogeneic Transplant for Pediatric Hematologic Malignancies (NCT01036009) | University of California, San Francisco | 2009-10-01 |
| Intensity Modulated Total Marrow Irradiation (IM-TMI) for Advanced Hematologic Malignancies (NCT00988013) | University of Illinois at Chicago | 2009-09-01 |
| Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry for Off-Label Transplant Use of Plerixafor (NCT01362985) | Genzyme, a Sanofi Company | 2009-07-01 |
| Pathogenesis of Hematologic Malignancies (NCT01728402) | OHSU Knight Cancer Institute | 2008-09-01 |
| Safety and Efficacy Study of Umbilical Cord Blood-Drived Mesenchymal Stem Cells to Promote Engraftment of Unrelated Hematopoietic Stem Cell Transplantation (NCT00823316) | Medipost Co Ltd. | 2008-08-01 |
| Clove In The Treatment Of Relapsed Or Resistant Acute Leukemia In Children (NCT01385891) | Istituto Giannina Gaslini | 2008-08-01 |
| A Study for Patients With Acute Leukemia (NCT01214655) | Eli Lilly and Company | 2008-06-01 |
| Chemotherapy and Unrelated Donor Stem Cell Transplantation for Patients With Cancers of the Blood and Immune System (NCT00520130) | National Cancer Institute (NCI) | 2007-10-30 |
| Phase I Dose-Escalation Trial of Clofarabine Followed by Escalating Doses of Fractionated Cyclophosphamide in Children With Relapsed or Refractory Acute Leukemias (NCT00852709) | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins | 2007-09-01 |
| Sharing Our Strength: A Research Study for Bone Marrow/Stem Cell Transplant Survivors (NCT00701844) | University of North Carolina, Chapel Hill | 2007-07-01 |
| An Observational Analysis of Voriconazole Therapeutic Drug Concentration Monitoring, Pharmacogenomics and Clinical Outcome Correlations in High-risk Hematology Patients (NCT01321372) | University Health Network, Toronto | 2007-06-01 |
| Trial of AVN-944 in Patients With Advanced Hematologic Malignancies (NCT00273936) | Vertex Pharmaceuticals Incorporated | 2006-01-01 |
| A Phase I Trial of ZIO-101 in Hematologic Cancers (NCT00592046) | Alaunos Therapeutics | 2005-05-01 |
| Fludarabine Based Conditioning for Allogeneic Transplantation for Advanced Hematologic Malignancies (NCT01499147) | University of Illinois at Chicago | 2000-02-01 |
| Unicentric Retrospective Analysis of a Cohort of 602 Young Adult and Adolescent Patients (AJA), Aged 15 to 30 Years, With Haematological Malignancies, and Managed Between 2000 and 2016 (NCT03469921) | Institut Paoli-Calmettes | 2000-01-01 |
| Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes (NCT00899223) | Alliance for Clinical Trials in Oncology | 1996-05-01 |
| Peripheral Blood (PB) Versus Bone Marrow (BM) in Allogeneic Stem Cell Transplantation (NCT01020175) | European Society for Blood and Marrow Transplantation | 1995-01-01 |
| Expanded Access to Immunomodulatory AVM0703 for Solid Tumor and Blood Cancer Patients (NCT05974410) | AVM Biotechnology Inc | |
| Study of the Level of a Protein Which Could Predict the Development of a Fungal Infection in Patients With Acute Leukemia (NCT02823132) | Centre Hospitalier Universitaire Dijon | |